Norfolk files suit against pharmaceutical companies

(ANITA) WHILE ELIZABETH CITY IS DEALING WITH THE WORST OVERDOSE SPIKE IN DECADES – NORFOLK IS TAKING ACTION IN THE OPIOID CRISIS. THE CITY HAS FILED SUIT AGAINST THE SOURCE OF SOME OF THESE DRUGS: PHARMACEUTICAL COMPANIES. 10 ON YOUR SIDE’S JASON MARKS TAKES US THROUGH THE LENGTHY LAWSUIT. (JASON) THERE IS PLENTY OF BLAME TO GO AROUND WHEN IT COMES TO THIS CRISIS BLAME LIES WITH THE COMPANIES WHO ARE MAKING THE DRUGS. (JASON MARKS) (DR. PRAVEEN DURGAMPUDI/ODU PROFESSOR) “IT’S A PRETTY LARGE ISSUE I WOULD SAY” .THAT LARGE ISSUE CONTINUES TO GROW. WE CONTINUE TO SEE MORE AND PRAVEEN DURGAMPUDI/ODU PROFESSOR) “ONE PART IS FROM THOSE USERS WHO ARE NOT AWARE OF FULL SIDE AFFECTS OF THE DRUGS IS ALSO CONTRIBUTING TO THE EXCEEDING NATURE OF MORE ER ADMISSIONS” ODU PROFESSOR DR. PRAVEEN DURGAMPUDI (DUR-GAM-PODEE) SAYS THE INCREASE IN OVERDOSES IS ALARMING. NORFOLK OFFICIALS FEEL THE SAME WAY. THAT’S WHY THEY JUST FILED A FEDERAL SUIT CLAIMING THE PHARMACEUTICAL COMPANIES WHO MAKE PRESCRIPTION PILLS ARE A PUBLIC NUISANCE AND MISREPRESENTING THE RISKS AND BENEFITS OF THE DRUGS. (JASON MARKS) “ACCORDING TO THE LAWSUIT 739 PEOPLE OVERDOSED ON OPIOIDS IN THE LAST TWO YEARS. 58 OF THOSE OVERDOSES WERE FATAL AND GET THIS THE CITY SAYS AN ADDITIONAL 65 PEOPLE DIED DUE TO OVERDOSES BETWEEN 2011 AND 2014″ NORFOLK OFFICIALS ARE ASKING A JURY TO AWARD DAMAGES FROM MORE THAN MEDICAL CARE AND TREATMENT FOR ADDICTS. PAY TO PROVIDE CARE FOR INFANTS BORN WITH OPIOID MEDICAL CONDITIONS AND PROVIDE FOR CHILDREN WHOSE PARENTS ARE ADDICTED. DR. DURGAMPUDI SAYS THIS DOESN’T JUST FALL ON THE COMPANIES BUT THE USERS. IS CAUSING THE WIDER SOCIETAL ISSUE NOW” THE ISSUE ISN’T SLOWING DOWN– NEITHER IS THE SEARCH FOR ANSWERS TO BRING THE CRISIS TO AN END. EDUCATING THE PUBLIC WHO CITY TO GO ABOUT THE DRUG COMPANIES. BOTH VIRGINIA BEACH AND CHESAPEAKE FILED SIMILAR FEDERAL LAW SUITS WITH IN THE LAST YEAR. YOU CAN READ THE LAW SUIT FOR YOURSELF ON WAVY.COM JASON MARKS 10 ON YOUR

2 comments

Leave a Reply

(*) Required, Your email will not be published